ScholarLens Back to search
2023•Journal of the American Academy of DermatologyOpen access

42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis

Vimal H. Prajapati, Lisa Swanson, Christian Jossart, Kyoungah See, Alyssa Garrelts, Gholamreza Safaee Ardekani, Yan-Cheng Chao, Perla Lansang

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ixekizumab, Secukinumab, Medicine, Etanercept, Psoriasis, Dermatology, Plaque psoriasis, Placebo

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis — Research Paper | ScholarLens